Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Sedana Medical

10.02 SEK

+0.60 %

Less than 1K followers

SEDANA

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+0.60 %
-0.60 %
-26.11 %
-17.46 %
-47.48 %
-21.23 %
-49.11 %
-84.67 %
+68.40 %

Sedana Medical operates in the medical technology industry and focuses on the development and manufacture of systems for inhalation anesthesia. The company's products are aimed at healthcare institutions and anesthesiologists. The business is global with a main presence in Europe, North America and Asia. Sedana Medical was founded in 2005 and is headquartered in Danderyd, Sweden.

Read more
Market cap
995.36M SEK
Turnover
1.06M SEK
Revenue
178.75M
EBIT %
-28.4 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
12/2
2026

Annual report '25

23/4
2026

Interim report Q1'26

27/5
2026

General meeting '26

All
Webcasts
Press releases
ShowingAll content types
Regulatory press release11/24/2025, 7:00 AM

Sedana Medical informerar om positivt pre-NDA-möte med FDA

Sedana Medical
Regulatory press release11/24/2025, 7:00 AM

Sedana Medical reports positive pre-NDA meeting with FDA

Sedana Medical
Regulatory press release10/24/2025, 5:00 AM

Sedana Medical AB:s Delårsrapport januari-september 2025

Sedana Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release10/24/2025, 5:00 AM

Sedana Medical AB’s Interim report January-September 2025

Sedana Medical
Regulatory press release10/21/2025, 10:47 AM

Finansinspektionen: Flaggningsmeddelande i Sedana Medical AB (publ)

Sedana Medical
Regulatory press release10/16/2025, 4:00 PM

Sedana Medicals valberedning inför årsstämman 2026

Sedana Medical
Regulatory press release10/16/2025, 4:00 PM

Sedana Medical’s Nomination Committee for the 2026 Annual General Meeting

Sedana Medical
Press release10/10/2025, 6:00 AM

Inbjudan till presentation av Sedana Medicals kvartalsrapport för tredje kvartalet 2025

Sedana Medical
Press release10/10/2025, 6:00 AM

Invitation to presentation of Sedana Medical’s interim report for the third quarter 2025

Sedana Medical
Regulatory press release7/18/2025, 5:00 AM

Sedana Medical AB:s Delårsrapport januari-juni 2025

Sedana Medical
Regulatory press release7/18/2025, 5:00 AM

Sedana Medical AB’s Interim report January-June 2025

Sedana Medical
Press release7/16/2025, 6:00 AM

Sedana Medicals pediatriska studie publicerad i The Lancet

Sedana Medical
Press release7/16/2025, 6:00 AM

Sedana Medical's paediatric study published in The Lancet

Sedana Medical
Press release7/4/2025, 6:00 AM

Inbjudan till presentation av Sedana Medicals kvartalsrapport för andra kvartalet 2025

Sedana Medical
Press release7/4/2025, 6:00 AM

Invitation to presentation of Sedana Medical’s interim report for the second quarter 2025

Sedana Medical
Press release6/10/2025, 6:00 AM

Båda Sedana Medicals registreringsgrundande studier i USA uppnår det första sekundära effektmåttet

Sedana Medical
Press release6/10/2025, 6:00 AM

Both of Sedana Medical´s pivotal US studies meet first key secondary endpoint

Sedana Medical
Regulatory press release5/15/2025, 3:00 PM

Kommuniké från Sedana Medical AB:s årsstämma den 15 maj 2025

Sedana Medical
Regulatory press release5/15/2025, 3:00 PM

Report from Sedana Medical AB’s annual general meeting on 15 May 2025

Sedana Medical
Regulatory press release5/6/2025, 5:00 AM

Sedana Medical AB:s Delårsrapport januari-mars 2025

Sedana Medical
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.